CCI Deep Dive - Are Umbilical Cord Stem Cells Better or a Scam?

 This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%), and the destructive multi-step supply chain that degrades these cells long before they reach a syringe. It also contrasts these products with high-viability autologous options such as bone marrow concentrate and adipose tissue, explaining when and why each is appropriate. The result is a blunt, evidence-driven guide that helps patients and providers separate science from marketing and understand what real regenerative therapy requires.